Early research (Phase 1)Ended earlyNCT02883426
What this trial is testing
Evaluating the Safety and Immunogenicity of a Live Attenuated Virus Vaccine to Prevent Influenza H3N2v Disease
Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 1